HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ELND005-AD201 Investigators Selected Research

scyllitol (scyllo-inositol)

9/2011A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


ELND005-AD201 Investigators Research Topics

Disease

1Alzheimer Disease (Alzheimer's Disease)
09/2011

Drug/Important Bio-Agent (IBA)

1scyllitol (scyllo-inositol)IBA
09/2011
1Amyloid (Amyloid Fibrils)IBA
09/2011
1Biomarkers (Surrogate Marker)IBA
09/2011

Therapy/Procedure

1Activities of Daily Living (ADL)
09/2011